Kidney Patients Group Commends Secretary Kennedy's Appointments to USPSTF for Enhanced Kidney Health

The American Association of Kidney Patients (AAKP) Welcomes New Appointments to USPSTF

On September 18, 2026, the American Association of Kidney Patients (AAKP) expressed strong support for the recent appointments made by U.S. Department of Health and Human Services Secretary, Robert F. Kennedy Jr., to the U.S. Preventive Services Task Force (USPSTF). The AAKP is recognized as the oldest and largest independent kidney patient advocacy organization in the United States and has long advocated for reform in kidney health policy.

The AAKP has emphasized the importance of improved screening and preventive measures aimed at those most at risk for kidney diseases—an issue that affects over 37 million Americans. The organization points out the alarming statistics of interconnected chronic conditions, stating that more than a quarter of the adult population is impacted by cardiovascular, kidney, and metabolic diseases, which contribute significantly to mortality rates.

In their prepared statements, AAKP leaders hailed the new appointments for bringing crucial medical expertise that aligns with goals of patient-centered care, particularly in the realm of kidney health. Edward V. Hickey, III, the AAKP President and a chronic kidney disease survivor, voiced his optimism, stating, “We applaud Secretary Kennedy for appointing medical professionals who possess a diverse range of experiences and qualifications. The AAKP has consistently called for reform within the USPSTF, highlighting issues surrounding their previous inaction that has adversely affected those most vulnerable to kidney disease.” He conveyed a vision of empowering patients through enhanced preventive care and scientific innovation.

Vice President Paul T. Conway, who himself is a kidney transplant recipient, echoed these sentiments by highlighting the newly appointed experts’ understanding of early disease prevention, support for rural and Native American health, and the innovative usage of technology within healthcare. Conway expressed a hope that the revamped USPSTF would prioritize research backed by evidence to alleviate burdens on patients and taxpayers.

The announcement was timely, coinciding with AAKP's launch of its KidneyVoter™ campaign, titled “50 States in 50 Days”. This initiative aims to rally kidney disease advocates, proactively engaging them in the political process. During this campaign, KidneyVoters™ leverage social media and mobilize their communities to hold Congress accountable for meaningful healthcare reforms impacting patient services.

The AAKP's advocacy extends beyond kidney health, addressing the broader interrelation of cardiovascular, diabetes, and bone health challenges. Their commitment to uniting the diverse kidney community has proven effective, with more than 500,000 voters engaged in prior KidneyVoter™ efforts.

Continuing their proactive approach, AAKP also linked kidney patients, donors, and caregivers with Congressional leaders through its All Kidney Policy is Local™ campaign during the recent Congressional recess. This initiative is crucial as it directly connects affected individuals to legislative processes that shape healthcare policy.

As the AAKP forges ahead, they remain motivated to influence the trajectory of kidney healthcare in the U.S. through bipartisan policies and substantial funding for kidney research, eyeing an increase of up to $1.8 billion from federal sources such as the National Institutes of Health and the Department of Defense.

In addition, the AAKP is dedicated to remaining vigilant against challenges posed by global competitors in biotechnology, particularly state-sponsored efforts from nations such as China. They recognize the importance of American innovation and leadership in ensuring equitable access to treatment and ongoing efforts in kidney health that can support long-term patient survival.

For updates, interested individuals can follow the AAKP on their social media platforms or visit their official website for more resources and advocacy details. Their work is vital and underscores a commitment to elevating kidney health issues at all governmental levels, ensuring patient voices are heard and acted upon.

With the momentum gained from these developments, the kidney patient advocacy community takes a giant step forward in addressing past inadequacies, driving for a healthier future for all Americans at risk for kidney disease.